Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Biology & Therapy

• Publication date

  2014-02-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cbt.27823PMID 24495954PMCID PMC3974825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Department of Biology

  2019cited by this paper
• Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma

  2013cited by this paper
• JAB1 Is Essential for B Cell Development and Germinal Center Formation and Inversely Regulates Fas Ligand and Bcl6 Expression

  2012cited by this paper
• Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

  2012influential reference
• The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

  2012cited by this paper
• Targeting Jab1/CSN5 in nasopharyngeal carcinoma.

  2012cited by this paper
• Deficiency of DNA repair nuclease ERCC1‐XPF promotes prostate cancer progression in a tissue recombination model

  2012cited by this paper
• Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.

  2012cited by this paper
• Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells

  2012cited by this paper
• Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27

  2012cited by this paper
• Functional, Genetic, and Epigenetic Aspects of Base and Nucleotide Excision Repair in Colorectal Carcinomas

  2012cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

  2011cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

  2011cited by this paper
• Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway

  2011cited by this paper
• The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation.

  2011cited by this paper
• Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.

  2010cited by this paper
• Fanconi anemia and breast cancer susceptibility meet again

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

  2010cited by this paper
• Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}.

  2010cited by this paper
• Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

  2010cited by this paper
• JAB1/CSN5: a new player in cell cycle control and cancer

  2010influential reference
• Origin of chromosomal translocations in lymphoid cancer.

  2010influential reference
• The DNA damage response: making it safe to play with knives.

  2010influential reference
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair

  2010influential reference
• A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

  2009cited by this paper
• Symmetrical modularity of the COP9 signalosome complex suggests its multifunctionality.

  2009cited by this paper
• Polyethylene Glycosylated Curcumin Conjugate Inhibits Pancreatic Cancer Cell Growth through Inactivation of Jab1

  2009influential reference
• DNA damage, aging, and cancer.

  2009cited by this paper
• Significance of Jab1 Expression in Human Esophageal Squamous Cell Carcinoma

  2009cited by this paper
• Genomic instability and the selection of treatments for cancer

  2009cited by this paper
• Jab1 has negative effects on p53-mediated genotoxic stresses.

  2009cited by this paper
• Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.

  2009cited by this paper
• How the fanconi anemia pathway guards the genome.

  2009cited by this paper
• Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

  2009cited by this paper
• Principles of cancer therapy: oncogene and non-oncogene addiction.

  2009cited by this paper
• The combined status of ATM and p53 link tumor development with therapeutic response.

  2009cited by this paper
• Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice.

  2009cited by this paper
• Overexpression of Jab1 in Hepatocellular Carcinoma and Its Inhibition by Peroxisome Proliferator-Activated Receptorγ Ligands In vitro and In vivo

  2008cited by this paper
• CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.

  2008cited by this paper
• The COP9 signalosome: more than a protease.

  2008cited by this paper
• Somatic mutations affect key pathways in lung adenocarcinoma

  2008cited by this paper
• Platinum Resistance: The Role of DNA Repair Pathways

  2008cited by this paper
• DNA repair pathways and hereditary cancer susceptibility syndromes.

  2007cited by this paper
• MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis.

  2007cited by this paper
• Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex.

  2007cited by this paper
• Ten genes for inherited breast cancer.

  2007cited by this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cited by this paper
• HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.

  2007cited by this paper
• Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice.

  2006cited by this paper
• Jab1 is a specificity factor for E2F1-induced apoptosis.

  2006cited by this paper
• Genetic regulators of large-scale transcriptional signatures in cancer

  2006cited by this paper
• Overexpression of jun activation domain‐binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features

  2006cited by this paper
• Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.

  2006cited by this paper
• Cytoplasmic Phospholipase A2 Levels Correlate with Apoptosis in Human Colon Tumorigenesis

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.

  2005cited by this paper
• Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice

  2005cited by this paper
• Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3

  2005cited by this paper
• Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex.

  2004cited by this paper
• Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks

  2004cited by this paper
• Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice*

  2004cited by this paper
• The COP9 signalosome.

  2003influential reference
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).

  2003cited by this paper
• The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage.

  2003cited by this paper
• 53BP1, a Mediator of the DNA Damage Checkpoint

  2002cited by this paper
• The Cytoplasmic Shuttling and Subsequent Degradation of p27Kip1 Mediated by Jab1/CSN5 and the COP9 Signalosome Complex*

  2002cited by this paper
• COP9 signalosome components play a role in the mating pheromone response of S. cerevisiae

  2002cited by this paper
• Crystal Structure of the Antioxidant Enzyme Glutathione Reductase Inactivated by Peroxynitrite*

  2002cited by this paper
• The Caenorhabditis elegans Skp1-related gene family: diverse functions in cell proliferation, morphogenesis, and meiosis.

  2002cited by this paper
• CSN5/Jab1 mutations affect axis formation in the Drosophila oocyte by activating a meiotic checkpoint.

  2002cited by this paper
• A unified view of the DNA-damage checkpoint.

  2002cited by this paper
• Defective DNA polymerase-δ proofreading causes cancer susceptibility in mice

  2001cited by this paper
• JAB1/CSN5 and the COP9 signalosome

  2001cited by this paper
• Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.

  2001cited by this paper
• BRCA2 is required for homology-directed repair of chromosomal breaks.

  2001cited by this paper
• Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice.

  2001cited by this paper
• The COP9 signalosome: from light signaling to general developmental regulation and back.

  2000cited by this paper
• Characterization of the mouse JAB1 cDNA and protein.

  2000cited by this paper
• The COP9 signalosome is essential for development of Drosophila melanogaster.

  1999cited by this paper
• DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139*

  1998influential reference
• mei-W68 in Drosophila melanogaster encodes a Spo11 homolog: evidence that the mechanism for initiating meiotic recombination is conserved.

  1998cited by this paper
• Arabidopsis Homologs of a c-Jun Coactivator Are Present Both in Monomeric Form and in the COP9 Complex, and Their Abundance Is Differentially Affected by the Pleiotropic cop/det/fus Mutations

  1998cited by this paper
• Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A.

  1998cited by this paper
• okra and spindle-B encode components of the RAD52 DNA repair pathway and affect meiosis and patterning in Drosophila oogenesis.

  1998cited by this paper
• The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch.

  1996cited by this paper
• A new group of conserved coactivators that increase the specificity of AP-1 transcription factors

  1996cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Mutation of a mutL homolog in hereditary colon cancer.

  1994cited by this paper
• The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

  1993cited by this paper
• Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein.

  1992cited by this paper

• A Novel CSN5 Inhibitor Drives Tumor-Intrinsic PD-L1 Degradation and Exerts Direct Antitumor Efficacy in Triple-Negative Breast Cancer.

  2026cites this paper
• Triazole-substituted pyrazole-pyrimidine hybrids as anticancer agents: synthesis, cytotoxicity, apoptosis mechanisms, and JAB1-targeted structure-based design.

  2026cites this paper
• β-catenin as a key regulator of the cisplatin response in tumor cells

  2025cites this paper
• Discovering New Metallo-Deubiquitinase CSN5 Inhibitors by a Non-Catalytic Activity Assay Platform.

  2024cites this paper
• Involvement of the Constitutive Photomorphogenesis 9 Signalosome Subunit 5 With Programmed Cell Death Protein 1 Ligand in Asthma

  2024cites this paper
• Circ_0084653 promotes the tumor progression and immune escape in triple-negative breast cancer via the deubiquitination of MYC and upregulation of SOX5.

  2024cites this paper
• Inactivation of Cops5 in smooth muscle cells causes abnormal reproductive hormone homeostasis and development in mice.

  2023cites this paper
• Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders

  2023cites this paper
• Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics

  2023cites this paper
• Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease

  2022cites this paper
• Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis

  2022cites this paper
• Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury

  2022cites this paper
• Ubiquitin proteasome system and autophagy associated proteins in human testicular tumors.

  2021cites this paper
• Jab1 (COPS5) as an Emerging Prognostic, Diagnostic and Therapeutic Biomarker for Human Cancer

  2021cites this paper
• Identification of Key Transcription Factors and Immune Infiltration Patterns Associated With Breast Cancer Prognosis Using WGCNA and Cox Regression Analysis

  2021cites this paper
• JAB1 deletion in oligodendrocytes causes senescence-induced inflammation and neurodegeneration in mice

  2021cites this paper
• Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer

  2021cites this paper
• Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response

  2021cites this paper
• PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1

  2021cites this paper
• Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma

  2021cites this paper
• Jab1/Cops5: a promising target for cancer diagnosis and therapy

  2021cites this paper
• Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helix β-d-glucan.

  2020cites this paper
• Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF

  2020cites this paper
• JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.

  2019cites this paper
• CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1

  2019cites this paper
• The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.

  2019cites this paper
• Over-expression of 5-HT6 Receptor and Activated Jab-1/p-c-Jun Play Important Roles in Pilocarpine-Induced Seizures and Learning-Memory Impairment

  2019cites this paper
• CSN5 attenuates Ang II‐induced cardiac hypertrophy through stabilizing LKB1

  2019cites this paper
• The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells.

  2019cites this paper
• An in silico study on plant-derived inhibitors against a prognostic Biomarker, Jab1

  2019cites this paper
• CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.

  2019cites this paper
• MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5

  2019cites this paper
• Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway

  2019cites this paper
• Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein-Barr virus, MicroRNAs, Long non-coding RNAs and Circular RNAs.

  2019cites this paper
• A nonsense mutant of the hepatitis B virus large S protein antagonizes multiple tumor suppressor pathways through c-Jun activation domain-binding protein1

  2018cites this paper
• Utility of Different Immunohistochemical Stain for Diagnosis of Invasive Breast Cancer

  2018cites this paper
• COP9 signalosome subunit CSN5, but not CSN6, is upregulated in lung adenocarcinoma and predicts poor prognosis.

  2018cites this paper
• S100A7, Jab1, and p27kip1 expression in psoriasis and S100A7 CRISPR‐activated human keratinocyte cell line

  2018cites this paper
• CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin.

  2018cites this paper
• Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer

  2018influential citation
• Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5

  2018cites this paper
• Bioinformatical identification of key pathways and genes in human hepatocellular carcinoma after CSN5 depletion.

  2018cites this paper
• Improved detection of gene-microbe interactions in the mouse skin microbiota using high-resolution QTL mapping of 16S rRNA transcripts

  2017cites this paper
• Jab1/Csn5 Signaling in Breast Cancer

  2017cites this paper
• Analysis of differential gene expression profile identifies novel biomarkers for breast cancer

  2017cites this paper
• Jab1/Csn5–Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress

  2017cites this paper
• CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation.

  2017cites this paper
• Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia

  2017cites this paper
• Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients

  2017cites this paper
• Jab1/Csn5 Signaling in Breast Cancer Jab1/Csn5 Signaling in Breast Cancer

  2017cites this paper
• Hsa-miR-24-3p Increases Nasopharyngeal Carcinoma Radiosensitivity by Targeting Both the 3’UTR and 5’UTR of Jab1/CSN5

  2016cites this paper
• Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway

  2016cites this paper
• COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR

  2016cites this paper
• Stat3 Contributes to Cancer Progression by Regulating Jab1/Csn5 Expression

  2016cites this paper
• The emerging roles of Jab1/CSN5 in cancer

  2016influential citation
• Immunodepletion and Immunopurification as Approaches for CSN Research.

  2016cites this paper
• Deubiquitinases in cancer

  2015cites this paper
• CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.

  2015cites this paper
• Reverse correlation of Jab1 and Smad4 in PANC-1 cells involved in the pathogenesis of pancreatic cancer.

  2015cites this paper
• Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways.

  2015cites this paper
• Role of macrophage migration inhibitory factor in age-related lung disease.

  2015cites this paper